Panel discussion session 2

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Prospects for Cure | Patrick Kennedy

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

State-of-the-art treatment of Hepatitis B | Cihan Yurdaydin, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Panel discussion Session 1

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Local situation in Russia | Vadim Rassokhin, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Local situation in Turkey | Serhat Unal, MD (Presented by Cihan Jurdaydin)

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Local situation in Georgia | Akaki Abutidze, MD, MPH, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Local situation in Czech and Slovak Republics | Viktor Aster, MD, PHD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Local situation in Poland | Miłosz Parczewski, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Local situation in Slovenia and the Balcan countries | Mojca Maticic, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Local situation in the Baltic countries | Saulius Caplinskas, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Local situation in Ukraine | Pavlo Skala

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Local situation in Romania | Oana Săndulescu, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Plenary Session 5 Discussion

APACC 2016

Innovative Clinical Models | Nittaya Phanuphak, MD, PhD

APACC 2016

Long Acting Antivirals for Treatment and Prevention | Martin Markowitz, MD

APACC 2016

Planery Session 4 Discussion

APACC 2016

Hepatitis - HIV Co-infection | Jürgen Rockstroh, MD

APACC 2016

Hepatitis C | Ching-lung Lai, MD, FRCP, FRACP

APACC 2016

Plenary Session 3 Discussion

APACC 2016

Integrating PrEP in prevention | Robert Grant, MD, MPH

APACC 2016

Plenary Session 2 Discussion

APACC 2016

Transmission networks among MSM | Shui-Shan Lee, MD, FRCP, FRCPA, FFPH

APACC 2016

HIV surveillance – Are we missing out on key populations? | Ying-Ru Lo, MD

APACC 2016